AI-Powered Proteomics & Drug Discovery
Supporting innovative proteomics R&D for 150+ industry, academic, and research institution clients worldwide.
Comprehensive solutions from proteomics research to AI-powered drug discovery and licensing.
World-class protein microarray analysis services. Achieve biochip-based proteomics research for successful bio R&D.
AI-powered drug discovery platform combining proteomics data with machine learning for accelerated target identification.
Strategic licensing and partnership opportunities for our proprietary drug candidates and platform technologies.
Advanced computational tools powered by our QUAI platform for structure-based drug design.
High-throughput molecular docking simulations to predict protein-ligand binding affinity.
AI-powered molecule generation using deep learning to design novel compounds.
Molecular dynamics simulations to study protein conformational changes and binding kinetics.
A CRO specialized in protein microarray-based proteomics — the cutting-edge of protein analysis technology.
Antibody Array
Still doing Western blot or ELISA? Now confirm up to 8,000 protein expressions in a single experiment.
Protein Chip
Verify antibodies and identify protein binding networks using 21,000 human protein chips.
Peptide Chip
Dramatically improve research efficiency by capturing all possible antigen epitopes on a single chip.
| Sample Type | Service |
|---|---|
| Antibody | Antibody specificity and cross-reactivity test |
| Epitope Mapping | |
| Cells / Tissue / Exosome | Multiple protein expression test (≈Western) |
| Multiple protein quantification (≈ELISA) | |
| Serum / Plasma | Autoantibody Biomarker Discovery |
| Multiple protein expression test (≈Western) | |
| Multiple protein quantification (≈ELISA) | |
| Proteins / Peptides / Chemicals | Human proteome binding assay |
Analyze protein and antibody expression in serum, cell, and tissue samples.
Equipped for infectious pathogens and specialized sample protein analysis.
Extensive experience in joint research and national R&D projects.
Proprietary drug candidates advancing through clinical development.
Alopecia Treatment
Novel therapeutic approach targeting hair follicle regeneration pathways identified through our proteomics platform.
Sarcopenia Treatment
First-in-class therapeutic candidate for age-related muscle loss, developed using AI-driven target identification.
From consultation to final report delivery — a seamless research experience.
Research consulting, NDA/MTA agreements, experiment scheduling
Microarray preparation, sample preprocessing, SDS-PAGE/Dot-blot tests
Microarray assays, high-resolution laser scanning, big data analysis
Data mining, graph generation, research report, raw data delivery
Discover how GeneOn’s AI-powered proteomics platform is revolutionizing drug discovery. Schedule a meeting with our team.
ENGLISH
